10x Genomics (NASDAQ:TXG – Free Report) had its price objective lowered by Stifel Nicolaus from $63.00 to $53.00 in a research note released on Wednesday, Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock. Several other research analysts also recently issued reports on TXG. TD Cowen downgraded 10x Genomics from a buy […]
10x Genomics (NASDAQ:TXG – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.50) EPS for the quarter, meeting the consensus estimate of ($0.50), Yahoo Finance reports. 10x Genomics had a negative net margin of 42.20% and a negative return on equity of 30.43%. The company had revenue of $141.01 million […]
10x Genomics (NASDAQ:TXG – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.50) EPS for the quarter, meeting the consensus estimate of ($0.50), Yahoo Finance reports. 10x Genomics had a negative net margin of 42.20% and a negative return on equity of 30.43%. The company had revenue of $141.01 million […]
10x Genomics (NASDAQ:TXG – Get Free Report) had its price target decreased by equities research analysts at Stifel Nicolaus from $63.00 to $53.00 in a note issued to investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ price target indicates a potential upside of 103.85% from the […]
10x Genomics (NASDAQ:TXG – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($0.50) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.50), Yahoo Finance reports. The business had revenue of $141.01 million for the quarter, compared to the consensus estimate of $142.24 million. 10x Genomics had […]